These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12387056)

  • 1. [Fidarestat (SNK-860)].
    Hibi C
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():594-600. PubMed ID: 12387056
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aldose reductase inhibitor SNK-860].
    Hibi C
    Nihon Rinsho; 1997 Nov; 55 Suppl():212-5. PubMed ID: 9434469
    [No Abstract]   [Full Text] [Related]  

  • 3. Fidarestat. Sanwa Kagaku/NC Curex/Sankyo.
    Giannoukakis N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1233-9. PubMed ID: 14649216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of myo-inositol and sorbinil studies.
    Clements RS
    Clin Physiol; 1985; 5 Suppl 5():90-3. PubMed ID: 3938689
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular biology in development and progression of diabetic retinopathy].
    Funatsu H; Yamashita H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():162-6. PubMed ID: 12430223
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.
    Schemmel KE; Padiyara RS; D'Souza JJ
    J Diabetes Complications; 2010; 24(5):354-60. PubMed ID: 19748287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent clinical experience with aldose reductase inhibitors.
    Krans HM
    Diabet Med; 1993; 10 Suppl 2():44S-48S. PubMed ID: 8334842
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Diabetic autonomic neuropathy" series. Epidemiology, pathogenesis, basic therapy and prognosis].
    Luft D
    MMW Fortschr Med; 2002 May; 144(20):47-50. PubMed ID: 12119885
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
    Hattori T; Matsubara A; Taniguchi K; Ogura Y
    Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural-functional interactions in the therapeutic response of diabetic neuropathy.
    Sima AA; Greene DA
    Diabet Med; 1993; 10 Suppl 2():33S-34S. PubMed ID: 8334838
    [No Abstract]   [Full Text] [Related]  

  • 13. Can aldose reductase inhibition ameliorate diabetic neuropathy?
    González ER
    JAMA; 1981 Sep; 246(11):1169-70. PubMed ID: 6790734
    [No Abstract]   [Full Text] [Related]  

  • 14. [SG-210].
    Akira T; Naka H
    Nihon Rinsho; 1997 Nov; 55 Suppl():216-20. PubMed ID: 9434470
    [No Abstract]   [Full Text] [Related]  

  • 15. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.
    Amano S; Yamagishi Si; Kato N; Inagaki Y; Okamoto T; Makino M; Taniko K; Hirooka H; Jomori T; Takeuchi M
    Biochem Biophys Res Commun; 2002 Nov; 299(2):183-8. PubMed ID: 12437967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential pharmacological treatments for diabetic retinopathy].
    Watanabe D; Takagi H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():244-9. PubMed ID: 15999714
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldose reductase inhibitors and diabetic complications.
    Tomlinson DR; Willars GB; Carrington AL
    Pharmacol Ther; 1992; 54(2):151-94. PubMed ID: 1438531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.
    Hotta N; Toyota T; Matsuoka K; Shigeta Y; Kikkawa R; Kaneko T; Takahashi A; Sugimura K; Koike Y; Ishii J; Sakamoto N;
    Diabetes Care; 2001 Oct; 24(10):1776-82. PubMed ID: 11574441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials of sorbinil on nerve function.
    Pfeifer MA
    Metabolism; 1986 Apr; 35(4 Suppl 1):78-82. PubMed ID: 3083211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aldose reductase inhibitors on the progression of nerve damage.
    Greene DA; Sima AA
    Diabet Med; 1993; 10 Suppl 2():31S-32S. PubMed ID: 8334837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.